Article thumbnail

Determinants of outcome in patients eligible for thrombolysis for ischemic stroke

By Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, Paolo Milia, Sergio Biagini and Giancarlo Agnelli
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2291319
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. 2004.Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy.
  2. (2003). Are changes in mortality from stroke caused by changes in stroke event rates or case fatality?
  3. (2004). Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.
  4. (2006). Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators.
  5. (1993). Classifi cation of subtype of acute ischemic stroke. Defi nitions for use in a multicenter clinical trial.
  6. (2002). Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusion after intravenous tissue plasminogen activator.
  7. (1998). Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.
  8. (1995). Early predictors of death after acute cerebral ischemic events.
  9. (2000). European Neurological Society and European Federation of Neurological Societies.
  10. (2006). Initiative recommendations for stroke management- update 2003. Cerebrovasc Dis,
  11. (1988). Interobserver agreement for the assessment of handicap in stroke patients.
  12. (1992). Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.
  13. (2005). Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients.
  14. (1995). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study.
  15. (2000). Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older. The t-PA Stroke Survey Experience.
  16. (2000). Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
  17. (2004). Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome.
  18. (1989). Maladie d’Alzheimer, analyse statistique des resultats du scanner X. Rev Neurol,
  19. (1996). Malignant middle cerebral artery territory infarction.
  20. (2002). Predicting functional outcome and survival after acute ischemic stroke.
  21. (2001). Predictors of good outcome after intravenous t-PA for acute ischemic stroke.
  22. (1998). Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II).
  23. (1992). Recombinant intravenous plasminogen activitor in acute thrombotic and embolic stroke. Ann Neurol, 32:78–86. European Stroke Initiative recommendations for stroke management.
  24. (1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Non-interventional Therapy in Ischemic Stroke.
  25. (1999). Stroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis?
  26. (1995). The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
  27. (1999). Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.
  28. (2002). Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature.
  29. (1998). Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
  30. (2001). Thrombolytic therapy for ischemic stroke – a review. Part I – Intravenous thrombolysis. Crit Care Med,
  31. (2001). Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke.
  32. (1989). Vascular Health and Risk Management 2007:3(5) 754 Caso et al
  33. (1999). World Health Organization -International Society of Hypertension Guidelines for the Management of Hypertension.